SciClone Pharma (赛生药业) Pre-IPO: Rejuvenation of Old Drugs

522 Views06 Oct 2020 14:29

SciClone Pharma was founded in the US but has a focus on sales of oncology and infectious disease drugs in China. The company plans to raise up to...

SUMMARY

(Sign Up to Access)

Get started on the Smartkarma Research Network with a complimentary Preview Pass to:

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

SMARTKARMA PREVIEW PASS

By signing up, you agree to our
Terms of Use and Privacy Policy.

Already have an account? Sign In Now

Full Insight

(Paid Plans Only, 6-minute read)

Discussions

(Paid Plans Only)

Top 5%

Asia Pac IPO & Placement Research, China biotech

Aequitas Research

EquitiesEquity Capital MarketsQuantitative Analysis

Price Chart(Sign Up to Access)

Insight Stream